AMAL vs HFWA

AMAL's Piotroski F-Score of 4/9 indicates a weak financial health profile, signaling potential operational inefficiencies or instability despite solid profitability metrics. The absence of an Altman Z-Score raises concern about default risk, especially given the lack of available leverage and liquidity data. While the stock trades below its intrinsic value of $80.65 and Graham Number of $45.21, suggesting undervaluation, the current price of $38.10 is significantly below both benchmarks, implying either deep value or market skepticism. Strong earnings growth (11.1% YoY) and consistent beat rates (3/4 in last 4 quarters) support future potential, but technical trends and insider selling undermine near-term momentum.

HFWA presents a compelling value opportunity, trading significantly below both its Graham Number ($34.59) and Intrinsic Value ($57.82). While the Piotroski F-Score of 4/9 indicates only stable financial health, the company is exhibiting explosive earnings growth (90.80% YoY) and a very attractive forward P/E of 9.35. Despite bearish insider sentiment and weak technical trends, the fundamental disconnect between the current price ($27.30) and the growth-adjusted value suggests a strong upside. The dividend remains sustainable with a payout ratio under 50%.